FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
Increased expression of both FGF proteins and their receptors observed in many cancers is often associated with the development of chemoresistance, limiting the effectiveness of currently used anti-cancer therapies. Malfunctioning of the FGF/FGFR axis in cancer cells generates a number of molecular...
Enregistré dans:
Auteurs principaux: | Jakub Szymczyk, Katarzyna Dominika Sluzalska, Izabela Materla, Lukasz Opalinski, Jacek Otlewski, Malgorzata Zakrzewska |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e265c83e558d4be7976e7d68c9528fa3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Biological Significance and Targeting of the FGFR Axis in Cancer
par: Athina-Myrto Chioni, et autres
Publié: (2021) -
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
par: Yunju Nam, et autres
Publié: (2022) -
Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
par: Karolina Jendryczko, et autres
Publié: (2021) -
The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration
par: Mariya Farooq, et autres
Publié: (2021) -
Heat Shock Proteins HSPA1 and HSP90AA1 Are Upregulated in Colorectal Polyps and Can Be Targeted in Cancer Cells by Anti-Inflammatory Oxicams with Arylpiperazine Pharmacophore and Benzoyl Moiety Substitutions at Thiazine Ring
par: Izabela Szczuka, et autres
Publié: (2021)